Fubon Financial Announces Fubon Life's Investment in Hamilton Lane Secondary Fund VII-B LP
Key facts
- Fubon Financial Announces Fubon Life's Investment in Hamilton Lane Secondary Fund VII-B LP
- Fubon Life, a subsidiary of Fubon Financial Holding Co., has announced the subscription to Hamilton Lane Secondary Fund VII-B LP, with a total commitment of up to USD 50 million, in compliance with insurance fund regulations.
- Source: PR Times
- Date: June 24, 2026
Direct answer
Fubon Life, a subsidiary of Fubon Financial Holding Co., has announced the subscription to Hamilton Lane Secondary Fund VII-B LP, with a total commitment of up to USD 50 million, in compliance with insurance fund regulations.
- Citation
- Fubon Financial Announces Fubon Life's Investment in Hamilton Lane Secondary Fund VII-B LP (June 24, 2026), PR Times
- Source
- PR Times
- Date
- June 24, 2026
Fubon Life, a subsidiary of Fubon Financial Holding Co., has announced the subscription to Hamilton Lane Secondary Fund VII-B LP, with a total commitment of up to USD 50 million, in compliance with insurance fund regulations.
📋 Article Processing Timeline
- 📰 Published: June 24, 2026 at 09:00
- 🔍 Collected: June 25, 2026 at 17:00 (32h 0m after Published)
- 🤖 AI Analyzed: June 25, 2026 at 18:22 (1h 22m after Collected)
1. Name and nature of the target (if preferred shares, specify terms such as dividend rate):
Hamilton Lane Secondary Fund VII-B LP private equity fund
2. Date of occurrence: 115/06/24
3. Number of units, unit price, and total transaction amount:
No transaction units, no unit price, total subscription amount not exceeding USD 50 million
4. Counterparty and its relationship with the company (if the counterparty is an individual and not a related party, name disclosure may be omitted):
Hamilton Lane Advisors, L.L.C., none
5. If the counterparty is a related party, state the reason for selecting them, previous transferor, relationships among the previous transferor, the company, and the counterparty, transfer date, and amount:
Not applicable
6. If the ownership of the target was held by a related party of the company within the past five years, state the date, price, and relationship with the company at the time of acquisition and disposal:
Not applicable
7. Matters related to the disposal of receivables (including types of collateral; if receivables from related parties, state names and book amounts):
Not applicable
8. Gain (or loss) from disposal (not applicable for acquisition of securities) (if deferred, list recognition details):
Not applicable
9. Delivery or payment terms (including period and amount), contractual restrictions, and other important agreements:
Delivery or payment terms: as stipulated in the private equity fund agreement
Contractual restrictions and other important agreements: as stipulated in the private equity fund agreement
10. Method of transaction decision, reference basis for pricing, and decision-making unit:
Method and pricing basis: as stipulated in the private equity fund agreement
Decision-making unit: according to the company's approval authority
11. Net asset value per share of the securities-issuing company:
Not applicable
12. Difference between private placement reference price and per-share transaction price exceeding 20%:
Not applicable
13. Cumulative holdings (including this transaction) of the securities, amount, ownership percentage, and rights restrictions (e.g., pledge status) to date:
Holding Co.: none
Life: no transaction units, not exceeding USD 50 million, approximately 0.71%, none
14. Proportion of private placement securities investment (including this transaction) to total assets and equity attributable to parent company owners in the latest financial statements, and amount of working capital in the latest financial statements:
Holding Co.: 29.97%, 36.26%, not applicable
15. Manager and brokerage fees:
Not applicable
16. Specific purpose or use of the acquisition or disposal of securities:
For life insurance fund deployment in accordance with insurance regulations
17. Dissenting opinions from directors regarding this transaction:
Not applicable
18. Whether this transaction is a related-party transaction:
No
19. Date of board approval:
Not applicable
20. Date of auditor acknowledgment or audit committee approval:
Not applicable
21. Whether accountants issued an adverse opinion on this transaction: No
22. Name of accounting firm:
Hongwei Certified Public Accountants
23. Name of accountant:
Lai Chia-Yi
24. Accountant license number:
Taiwan Financial Certification Registration (6) No. 4408
25. Other explanatory matters:
None
Hamilton Lane Secondary Fund VII-B LP private equity fund
2. Date of occurrence: 115/06/24
3. Number of units, unit price, and total transaction amount:
No transaction units, no unit price, total subscription amount not exceeding USD 50 million
4. Counterparty and its relationship with the company (if the counterparty is an individual and not a related party, name disclosure may be omitted):
Hamilton Lane Advisors, L.L.C., none
5. If the counterparty is a related party, state the reason for selecting them, previous transferor, relationships among the previous transferor, the company, and the counterparty, transfer date, and amount:
Not applicable
6. If the ownership of the target was held by a related party of the company within the past five years, state the date, price, and relationship with the company at the time of acquisition and disposal:
Not applicable
7. Matters related to the disposal of receivables (including types of collateral; if receivables from related parties, state names and book amounts):
Not applicable
8. Gain (or loss) from disposal (not applicable for acquisition of securities) (if deferred, list recognition details):
Not applicable
9. Delivery or payment terms (including period and amount), contractual restrictions, and other important agreements:
Delivery or payment terms: as stipulated in the private equity fund agreement
Contractual restrictions and other important agreements: as stipulated in the private equity fund agreement
10. Method of transaction decision, reference basis for pricing, and decision-making unit:
Method and pricing basis: as stipulated in the private equity fund agreement
Decision-making unit: according to the company's approval authority
11. Net asset value per share of the securities-issuing company:
Not applicable
12. Difference between private placement reference price and per-share transaction price exceeding 20%:
Not applicable
13. Cumulative holdings (including this transaction) of the securities, amount, ownership percentage, and rights restrictions (e.g., pledge status) to date:
Holding Co.: none
Life: no transaction units, not exceeding USD 50 million, approximately 0.71%, none
14. Proportion of private placement securities investment (including this transaction) to total assets and equity attributable to parent company owners in the latest financial statements, and amount of working capital in the latest financial statements:
Holding Co.: 29.97%, 36.26%, not applicable
15. Manager and brokerage fees:
Not applicable
16. Specific purpose or use of the acquisition or disposal of securities:
For life insurance fund deployment in accordance with insurance regulations
17. Dissenting opinions from directors regarding this transaction:
Not applicable
18. Whether this transaction is a related-party transaction:
No
19. Date of board approval:
Not applicable
20. Date of auditor acknowledgment or audit committee approval:
Not applicable
21. Whether accountants issued an adverse opinion on this transaction: No
22. Name of accounting firm:
Hongwei Certified Public Accountants
23. Name of accountant:
Lai Chia-Yi
24. Accountant license number:
Taiwan Financial Certification Registration (6) No. 4408
25. Other explanatory matters:
None
FAQ
What is Fubon Life's investment target in this announcement?
Hamilton Lane Secondary Fund VII-B LP, a U.S.-based private equity fund.
How much is the investment amount?
Up to $50 million, as part of strategic asset allocation.
What is the purpose of this investment?
To diversify and stabilize returns through compliant insurance fund deployment.